author-photo

Seth M. Steinberg

National Institutes of Health

1044

Papers

83449

Citations

Citation Trend

Filter By

Papers (1044) Sort By

Journal Conference Others

P63.09 Surgical Management of Cushing's Syndrome Secondary to Lung Carcinoid Tumors: Changing Perspectives

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
First-in-human phase I/II trial of PRGN-2009 vaccine as monotherapy or with bintrafusp alfa in patients with recurrent/metastatic (R/M) human papillomavirus (HPV)-associated cancers (HPVC) and as neoadjuvant/induction therapy in locoregionally advanced (LA) HPV oropharyngeal (OP) and sinonasal (SN) squamous cell cancer (SCC).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variant.

2021 Blood Advances
Show All
- Source
- Cite
- Save
Citations (0)
664P Final results from phase I trial of cabozantinib/nivolumab (CaboNivo) alone or with ipilimumab (CaboNivoIpi) and peripheral immunity in metastatic genitourinary (mGU) tumors

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Adverse Events Following CAR T-Cell Therapy: A Single Institution Retrospective Analysis of Toxicities Following CAR T-Cell Therapy for Children and Young Adults with Relapsed Refractory B-Cell Acute Lymphoblastic Leukemia

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma: A Phase 2 Nonrandomized Controlled Trial.

2021 JAMA Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Immune Correlates from a Prospective Trial Suggest Leukotriene Signaling and Alternative Macrophage Activation in Clinical Bronchiolitis Obliterans Syndrome

2021
Show All
- Source
- Cite
- Save
Citations (0)
Avelumab, a PD-L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma.

2021 Oncologist
Show All
- Source
- Cite
- Save
Citations (4)
Phase 2 Study of Acalabrutinib Window Prior to Frontline Therapy in Untreated Aggressive B-Cell Lymphoma: Preliminary Results and Correlatives of Response to Acalabrutinib

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (15)